Li Chen, Ph.D., DABT, is currently a Principal Investigator and Digital Pathology Lead at PharmaNest since 2015. Previously, they served as a Pharmacology Scientist at Eli Lilly and Company from 2011 to 2015 and as a Senior Scientist at Hoffmann-La Roche from 2007 to 2011. Li is pursuing a Doctor of Philosophy in Pharmacology and Toxicology at the University of Medicine and Dentistry of New Jersey and holds a Bachelor’s degree in Molecular Biology and Biochemistry from Rutgers University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices